Among the signaling molecules involved with MSC migration to the tumor site are CXCL12/CXCR4 [8], CCL2 in Breast cancer, and SDF-1 in colorectal, prostate, and breast cancers [9]. The gene discussed is CCL2; the disease is breast carcinoma.